1. Home
  2. PHGE vs GTI Comparison

PHGE vs GTI Comparison

Compare PHGE & GTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHGE
  • GTI
  • Stock Information
  • Founded
  • PHGE 2015
  • GTI 2019
  • Country
  • PHGE Israel
  • GTI Malaysia
  • Employees
  • PHGE N/A
  • GTI N/A
  • Industry
  • PHGE Biotechnology: Pharmaceutical Preparations
  • GTI
  • Sector
  • PHGE Health Care
  • GTI
  • Exchange
  • PHGE Nasdaq
  • GTI NYSE
  • Market Cap
  • PHGE 14.6M
  • GTI 16.2M
  • IPO Year
  • PHGE N/A
  • GTI N/A
  • Fundamental
  • Price
  • PHGE $0.50
  • GTI $0.10
  • Analyst Decision
  • PHGE Strong Buy
  • GTI
  • Analyst Count
  • PHGE 2
  • GTI 0
  • Target Price
  • PHGE $20.00
  • GTI N/A
  • AVG Volume (30 Days)
  • PHGE 85.8K
  • GTI 34.0M
  • Earning Date
  • PHGE 05-15-2025
  • GTI 06-10-2025
  • Dividend Yield
  • PHGE N/A
  • GTI N/A
  • EPS Growth
  • PHGE N/A
  • GTI N/A
  • EPS
  • PHGE N/A
  • GTI N/A
  • Revenue
  • PHGE N/A
  • GTI N/A
  • Revenue This Year
  • PHGE N/A
  • GTI N/A
  • Revenue Next Year
  • PHGE N/A
  • GTI N/A
  • P/E Ratio
  • PHGE N/A
  • GTI N/A
  • Revenue Growth
  • PHGE N/A
  • GTI N/A
  • 52 Week Low
  • PHGE $0.45
  • GTI $0.07
  • 52 Week High
  • PHGE $4.90
  • GTI $6.60
  • Technical
  • Relative Strength Index (RSI)
  • PHGE 40.96
  • GTI 40.83
  • Support Level
  • PHGE $0.45
  • GTI $0.12
  • Resistance Level
  • PHGE $0.52
  • GTI $0.21
  • Average True Range (ATR)
  • PHGE 0.04
  • GTI 0.04
  • MACD
  • PHGE -0.00
  • GTI -0.01
  • Stochastic Oscillator
  • PHGE 39.31
  • GTI 4.23

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).

About GTI GRAPHJET TECHNOLOGY

Graphjet Technology is a company that owns state-of-the-art technology for the manufacture of artificial graphene and graphite, critical raw materials used in a variety of industries. The technology was developed through our collaboration with National University of Malaysia and Universiti Teknikal Malaysia Melaka. It produces artificial graphite and graphene from palm seed kernels, a waste product widely available in Malaysia and other countries that produce palm seed oil. Unlike mineral coal-based or petroleum-based graphite which is ultimately limited and must be mined and processed to produce commercial-grade graphite, our raw materials are renewable and effectively unlimited.

Share on Social Networks: